Turtle Creek Wealth Advisors, LLC Astrazeneca PLC Transaction History
Turtle Creek Wealth Advisors, LLC
- $847 Billion
- Q2 2025
A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 57,730 shares of AZN stock, worth $4.25 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
57,730
Previous 43,787
31.84%
Holding current value
$4.25 Million
Previous $3.22 Billion
25.35%
% of portfolio
0.48%
Previous 0.48%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...